Literature DB >> 15342934

Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.

Shosaku Nomura1, Norihito Inami, Shigenori Kanazawa, Toshiji Iwasaka, Shirou Fukuhara.   

Abstract

The kinetics of peripheral blood stem cell mobilization in response to recombinant human granulocyte colony-stimulating factor is well established. However, there have been few investigations of platelet activation markers during peripheral blood stem cell harvest. We measured the levels of the platelet activation markers, chemokines, and soluble factors in plasma obtained from patients undergoing peripheral blood stem cell harvest. The number of leukocytes, CD34+ cells, neutrophils, monocytes, and lymphocytes peaked on day 5 after granulocyte colony-stimulating factor treatment, but the numbers of eosinophils and basophils showed no significant change. Regulated on activation normally T-cell expressed and secreted (RANTES) level increased through day 10, and the monocyte chemotactic peptide-1 (MCP-1) level peaked on day 5. Platelet counts continued to increase through day 10. The level of thrombopoietin significantly increased on day 3, peaked on day 5, and decreased slightly by day 10. The levels of soluble CD40 ligand and soluble P-selectin increased up to day 5. The platelet-derived microparticle level peaked on day 5, and then began to decline. CD34+ cell numbers significantly correlated with those of leucocytes, neutrophils, monocytes, and lymphocytes, as well as levels of MCP-1, and the CD34+ cells exhibited changes similar to platelet-derived microparticles. The patterns of change in MCP-1, platelet-derived microparticles, and the CD34+ cell count are similar in that each peaks on day 5 and decreases thereafter. Further study is required to determine if a cause-and-effect relationship in their pattern of change exists among them.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342934     DOI: 10.1634/stemcells.22-5-696

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

Review 1.  G-CSF in Healthy Allogeneic Stem Cell Donors.

Authors:  Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-22       Impact factor: 3.747

Review 2.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

3.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

4.  Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Authors:  Sumithira Vasu; Susan F Leitman; John F Tisdale; Matthew M Hsieh; Richard W Childs; A John Barrett; Daniel H Fowler; Michael R Bishop; Elizabeth M Kang; Harry L Malech; Cynthia E Dunbar; Hanh M Khuu; Robert Wesley; Yu Y Yau; Charles D Bolan
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

5.  Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells.

Authors:  Rudolf Richter; Andrea Jochheim-Richter; Felicia Ciuculescu; Katarina Kollar; Erhard Seifried; Ulf Forssmann; Dennis Verzijl; Martine J Smit; Xavier Blanchet; Philipp von Hundelshausen; Christian Weber; Wolf-Georg Forssmann; Reinhard Henschler
Journal:  Stem Cells Dev       Date:  2014-05-27       Impact factor: 3.272

Review 6.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

7.  Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan.

Authors:  Hideaki Yoshimura; Masaaki Hotta; Takahisa Nakanishi; Shinya Fujita; Aya Nakaya; Atsushi Satake; Tomoki Ito; Kazuyoshi Ishii; Shosaku Nomura
Journal:  J Blood Med       Date:  2017-01-24

8.  Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device.

Authors:  Joel C Wojciechowski; Srinivas D Narasipura; Nichola Charles; Deanne Mickelsen; Kuldeeepsinh Rana; Martha L Blair; Michael R King
Journal:  Br J Haematol       Date:  2008-01-22       Impact factor: 6.998

9.  Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis.

Authors:  Tzu-Lin Chen; Ya-Wen Chiang; Guan-Ling Lin; Hsin-Hou Chang; Te-Sheng Lien; Min-Hua Sheh; Der-Shan Sun
Journal:  Stem Cell Res Ther       Date:  2018-05-02       Impact factor: 6.832

10.  Examination of biomarker expressions in sepsis-related DIC patients.

Authors:  Michiomi Shimizu; Akiko Konishi; Shosaku Nomura
Journal:  Int J Gen Med       Date:  2018-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.